The small conductance calcium-activated K ؉ channel gene SKCa3/KCNN3 maps to 1q21, a region strongly linked to schizophrenia. Recently, a 4-base pair deletion in SKCa3 was reported in a patient with schizophrenia, which truncates the protein at the end of the N-terminal cytoplasmic region (SKCa3⌬). We generated a green fluorescent protein-SKCa3 N-terminal construct (SKCa3-1/ 285) that is identical to SKCa3⌬ except for the last two residues. Using confocal microscopy we demonstrate that SKCa3-1/285 localizes rapidly and exclusively to the nucleus of mammalian cells like several other pathogenic polyglutamine-containing proteins. This nuclear targeting is mediated in part by two polybasic sequences present at the C-terminal end of SKCa3-1/285. In contrast, full-length SKCa3, SKCa2, and IKCa1 polypeptides are all excluded from the nucleus and express as functional channels. When overexpressed in human Jurkat T cells, SKCa3-1/285 can suppress endogenous SKCa2 currents but not voltage-gated K ؉ currents. This dominant-negative suppression is most likely mediated through the co-assembly of SKCa3-1/285 with native subunits and the formation of non-functional tetramers. The nuclear localization of SKCa3-1/285 may alter neuronal architecture, and its ability to dominantly suppress endogenous small conductance K Ca currents may affect patterns of neuronal firing. Together, these two effects may play a part in the pathogenesis of schizophrenia and other neuropsychiatric disorders.
Ca
2ϩ signaling cascades play a critical role in the functional activity of diverse tissues. Ca 2ϩ -activated K ϩ (K Ca ) 1 channels modulate Ca 2ϩ -mediated events by regulating the membrane potential in both excitable and non-excitable cells. K Ca channels are divided into three groups (big, intermediate, and small) based on their single channel conductance (1) . The small conductance SK Ca channels have unitary conductances of 4 -14 pS, are voltage-independent, and open in response to an increase in cytosolic [Ca 2ϩ ] i in the 200 -500 nM range (2, 3) . These channels are expressed in the central nervous system, where they modulate the firing pattern of neurons by generating slow membrane after-hyperpolarizations (3) (4) (5) . Three genes (SKCa1-3) (6) with a conserved genomic organization (7) encode SK Ca channels, their gene products bearing 70 -80% amino acid sequence identity. Functional SK Ca channels are formed from the homo-or heterotetrameric association of the SKCa1-3 subunits, each subunit containing six transmembrane helices (S1-S6) and intracellular N and C termini (8) . Calcium-dependent gating of SK Ca channels is mediated by calmodulin tightly complexed to the C terminus of each subunit (9, 10) .
The human SKCa3 gene (also known as KCNN3 and SK3) has been implicated in schizophrenia (11) , a psychiatric disorder that affects ϳ1% of all human populations. The gene maps to human chromosome 1q21 (12) , a region containing a major susceptibility locus for some forms of familial schizophrenia (13) . The SKCa3 channel contains a highly polymorphic polyglutamine repeat in its N terminus (11) . Association studies on diverse human populations have shown that longer repeats are significantly over-represented in patients with schizophrenia (11, 12, 14 -17) , and one study (16) has further demonstrated that longer repeat alleles are associated with the negative symptoms of the disease. However, one family study reported over-representation of short alleles in schizophrenia (18) , whereas several other association and family studies have failed to confirm any association between polyglutamine length in SKCa3 and schizophrenia (19 -24) . Recently, a rare 4-base pair deletion in the SKCa3 gene was identified in a patient with schizophrenia (25) . The truncated protein spans the entire N terminus and lacks the hydrophobic core and C terminus. Interestingly, the SKCa3 N-terminal region contains two polybasic putative nuclear localizing signals (NLS), raising the possibility that the mutant protein might traffic to the nucleus as has been reported for several pathogenic alleles of other polyglutamine-repeat proteins (26 -30) , either alone or in combination with the product of the normal allele. Given the tetrameric nature of these channels, the mutant protein might also co-assemble with normal SK Ca subunits encoded by all three loci in this gene family and suppress all endogenous SK Ca currents in a dominant-* This work was supported in part by National Institutes of Health Grants MH59222 (to K. G. C., J. J. G., and M. D. C.) and NS14609 (to M. D. C.), by a Feodor Lynen fellowship from the Alexander von Humboldt Foundation (to H. R.), and by a Trousdale fellowship (to H. T.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. negative manner. Such suppression has recently been demonstrated with an N-terminal SKCa2 fragment analogous to the truncated N-terminal SKCa3 protein (31) .
In the present study we compared the intracellular trafficking of GFP-tagged full-length K Ca proteins or a N-terminal SKCa3 protein (SKCa3-1/285) in mammalian cells and visualized the subcellular localization of these fusion proteins by confocal microscopy. Also, the dominant-negative effect of SKCa3-1/285 overexpression on endogenous SKCa2 currents in human Jurkat T cells was characterized by whole-cell patch clamp recording.
EXPERIMENTAL PROCEDURES
GFP Constructs-The GFP-tagged human SKCa2, SKCa3, and IKCa1 cDNAs have been described (7, 31, 32) . The C-terminal GFPtagged constructs were generated in the pEGFP-NI expression vector (CLONTECH, Palo Alto, CA). SKCa3-1/285 and the deletions (SKCa3-1/270 and SKCa3-1/175) were generated using polymerase chain reaction (PCR) to engineer both a 5Ј EcoRI site near the start codon and a 3Ј BamHI site at the appropriate position. These PCR fragments were cloned in-frame into pEGFP-C1 (CLONTECH) to create two N-terminal GFP fusion constructs.
Cell Lines-All cell lines and media were purchased from ATCC, Manassas, VA and maintained according the ATCC protocols at 37°C in 5% CO 2 and with 2 mM glutamine and 10% FCS (except as noted). Green monkey kidney (COS-7), rat basophilic leukemic (RBL) cells, human embryonic kidney (HEK), mouse pheochromocytoma (PC12), and mouse fibroblasts (L929) cells were cultured in DMEM, Jurkat T cells (E61) were grown in RPMI, and the human neuroblastoma (SK-N-SH) cell line was grown in DMEM with 20% FCS.
Transfection of Constructs into Mammalian Cells-Cells (5 ϫ 10 5 cells/ ring) were plated in culture chambers constructed by attaching a rubber ring to a glass coverslip with Sylgard and enclosing these rings in a sterile cell culture dish. Cells were transiently transfected with the GFP constructs and controls using the FuGene 6 transfection reagent (Roche Molecular Biochemicals, Indianapolis, IN) following the manufacturer's recommended protocol in OptiMEM media. Following an 8 -12-h transfection, the cells were placed in DMEM supplemented with 10% FCS and 2 mM glutamine and incubated at 37°C in 5% CO 2 for 24 h. The DNA vectors used for transfection were prepared using the Qiagen endotoxinfree Midi plasmid prep kit (Qiagen, Inc., Valencia, CA).
Confocal and Transmission Light Microscopy-Following transfection, confocal fluorescent images were taken with a Bio-Rad MRC-600 (Bio-Rad) equipped with an Argon laser (488 nm) and a fluorescein isothiocyanate filter set (500 -530 nm). All images were acquired under a 63ϫ oil immersion objective. The Scion image program (NIH, Bethesda, MD) was used to determine the pixel densities of nuclear and cytosolic fluorescence that are shown as figure insets.
Electrophysiology-To assess functional expression of ion channels, whole-cell recordings were carried out according to standard procedures (31) .
RESULTS

SKCa3-1/285 Localizes in the Nucleus of Transfected
Mammalian Cells-An alignment of the truncated SKCa3 protein SKCa3⌬ sequence with that of SKCa1, SKCa2, and IKCa1 is shown in Fig. 1 (25) . The SKCa3 protein is unique in the SK Ca channel subfamily in that it contains two polyglutamine-repeat cassettes separated by a proline-rich segment with six repeats of the putative SH3 binding motif PXXP. The remaining ϳ100 residues of SKCa3⌬ contain two polybasic regions that may function as NLS motifs. The proximal polybasic motif NLS1 is present in SKCa3 and partially present in SKCa2, whereas the distal motif NLS2 is present in all four channels.
To determine whether SKCa3⌬ can traffic to the nucleus, we generated a GFP-tagged N-terminal SKCa3 construct, GFPSKCa3-1/285, that is identical to SKCa3⌬ up to Leu 283 but contains Ser 284 and Asp 285 from AF031815 in place of the three frameshifted residues in SKCa3⌬. SKCa3-1-285 was transfected into COS-7 cells, and the fluorescent fusion protein was visualized by confocal microscopy. As controls, we evaluated the subcellular localization of the GFP-tagged full-length channels, SKCa3, SKCa2, and IKCa1. The three full-length channel constructs are excluded from the nucleus and are seen in presumptive endoplasmic reticulum and surface membranes (Fig.  2, A-C) . Patch clamp studies have shown that these GFPtagged channels function normally (7, 31, 32) . In striking contrast, SKCa3-1/285 localizes exclusively in the nucleus of COS-7, regardless of whether the GFP tag is on the N-terminal (Fig. 2D) or C-terminal end (Fig. 3A) . Nuclear targeting is rapid, occurring as early as 6 h after transfection (data not shown). Nuclear trafficking is also seen in the human Jurkat T cell line (Fig. 3B ) and the human neuroblastoma line SK-N-SH (Fig. 3C) , as well as in PC12, RBL, and L929 fibroblasts and HEK cells (data not shown). Deletion of the region containing the distal NLS2 motif (GFP-SKCa3-1/270) attenuates the exclusive nuclear staining, the fusion protein being seen in both the nucleus and cytoplasm (Fig. 3D) . A further deletion that removes both NLS motifs (GFP-SKCa3-1/175) produces a similar labeling pattern with brightly staining nuclei, diffuse cytoplasmic labeling, and weak membrane staining (data not shown). This nuclear localization was unexpected, because an N-terminal SKCa2 fragment containing similar motifs was excluded from the nucleus (31) . Taken together, these data confirm the hypothesis that SKCa3-1/285 traffics into the nucleus mediated in part by the region containing the distal NLS.
GFP-SKCa3-1/285 Suppresses Endogenous SK Ca CurrentsGiven that functional SK Ca channels are homo-or heterotetramers of SKCa1-3 subunits, SKCa3-1/285 might co-assemble with native SK Ca subunits to produce non-functional tetramers. Consistent with this idea, a recent study demonstrated dominantnegative suppression of native SKCa2 channels in human Jurkat T cells transfected with an N-terminal SKCa2 fragment analogous to SKCa3-1/285 (31) . Similar suppression of endogenous voltage-gated K ϩ currents has been observed in cells transfected with K V N-terminal fragments containing the structurally defined tetramerization domain (33) .
To test whether SKCa3-1/285 can suppress endogenous currents, we transfected GFP-SKCa3-1/285 into Jurkat T cells that are known to express SKCa2 and Kv1.3 currents (34, 35) . Patch clamp experiments were performed in control and GFPSKCa3-1/285-transfected Jurkat cells. Fig. 4A shows a ramp protocol eliciting K ϩ currents in human Jurkat T lymphocytes. The SKCa2 channels produce K ϩ currents at potentials more negative than Ϫ40 mV, whereas at depolarized potentials voltage-gated Kv1.3 channels and SKCa2 channels both contribute (Fig. 4B) compared with control cells, without affecting endogenous Kv1.3 currents. These results, taken together with earlier published data (31) , indicate that SKCa3-1/285 can suppress endogenous SKCa2 currents via tetramerization with native subunits. DISCUSSION We have used confocal microscopy to demonstrate dramatic and exclusive nuclear localization of a truncated N-terminal SKCa3 protein, SKCa3-1/285, in mammalian cells. This construct, with the exception of two residues at the C terminus, is identical to SKCa3⌬, a mutant protein found in a patient with schizophrenia. Nuclear targeting is mediated in part by two polybasic NLS motifs, and this localization might have deleterious effects on neuronal architecture and/or function. Parallel patch clamp experiments show that SKCa3-1/285 can selectively suppress endogenous SKCa2 currents (Fig. 4) , presumably by co-assembly with newly synthesized wild-type SK Ca subunits producing non-functional tetramers. These results suggest a potent dominant-negative mechanism whereby SKCa3-1/285 may affect the function of the entire class of SK Ca channels and thereby possibly alter brain function in schizophrenia.
SKCa3 transcripts are distributed in human and rat brain, including the substantia nigra, ventral tegmental area, caudate-putamen, amygdala, thalamus, medial habenula, lateral septal nucleus, dorsal raphe, hippocampus, and supraoptic nucleus (6, 12, 36 -38) . SKCa1 and SKCa2 transcripts have an overlapping pattern of expression and are also present in many of these regions (36) , suggesting that channel redundancy might mask even homozygous null mutations at any one locus. Dominant-negative suppression by SKCa3-1/285 could lead to a global reduction of the entire family of SKCa1-SKCa3 channels in a fashion more potent than traditional allelic genetic suppression involving a single locus. Such reduction of all endogenous SK Ca currents in regions of the brain, many of them rich in dopamine-containing neurons, might have effects analogous to the neurotoxic SK Ca blocker apamin. Blockade of SK Ca currents by apamin in brain slices is known to inhibit the post-spike afterhyperpolarization and change the firing pattern in dopamine-containing neurons from a pacemaker-like discharge into a multiple bursting pattern (39 -41) . In fact, recent studies demonstrate that SKCa3 is the intrinsic pacemaker of dopaminergic neurons in the substantia nigra (5) . Bursting activity in turn has been associated with increased dopamine release (40 -44) . Apamin has also been reported to increase serotonin release in rat striatum (45) . If dominantnegative suppression by SKCa3-1/285 has similar functional consequences, it might affect dopaminergic and serotonergic pathways in the brain that have been implicated in schizophrenia (46) . The nuclear localization of SKCa3-1/285 is reminiscent of the nuclear trafficking of other pathogenic polyglutamine proteins such as huntingtin (26 -30) . Although the two polyglutamine tracks in SKCa3-1/285 are shorter (12 and 14 Gln) than the critical threshold reported to be pathogenic for other proteins, a monoclonal antibody specific for expanded polyglutamine-containing proteins (Ͼ40 Q-long) has been shown to recognize the human SKCa3 protein (47) . Thus, the tandem polyglutamine repeats and the intervening PXXP-containing polyproline segment in SKCa3-1/285 might mimic longer pathogenic polyglutamine repeats. Although the consequences of nuclear localization of SKCa3-1/285 are not yet known, any effect it has on the viability or architecture of neurons could be associated with the pathogenesis of schizophrenia. In keeping with this notion, postmortem and neuroimaging studies on schizophrenic brains have revealed a decrease in brain volume presumably because of a reduction of neuritic processes (48, 49) . The presence of a putative proline-rich SH3-binding domain in the SKCa3 N terminus also raises the possibility that SKCa3-1/285 may bind to critical signaling molecules and potentially alter their subcellular localization and function.
